Factors modulating supernumerary hair cell production in the postnatal rat cochlea in vitro.
It has been shown in the past that extra hair cells or supernumerary cells can be produced when neonatal cochleae are maintained in vitro. In this report, we investigated the effects of the culture methods, molecules and growth factors that are thought to be involved in cell proliferation. Quantitative studies of supernumerary hair cells were made by measuring the cell density over the entire spiral lamina at two postnatal stages: birth and 3 days after birth. With a standard feeding solution without serum, a difference in cell density was observed between the two methods of culture. Cochlear explants in a standard feeding solution supplemented with serum showed an increase of cell density only when the explantation is made at birth. Retinoic acid added to the standard feeding solution did not increase the hair cell density, while insulin induced an increase, especially at 5 micrograms/ml. Several growth factors were tested. Epidermal growth factor (EGF) presented a dose dependent effect with an increase of up to 30% of hair cell density that was observed in the basal region when the explantation was made at birth. Transforming growth factor-alpha did not induce an increase of cell density, whereas transforming growth factor-beta presented an effect on hair cell density, with a dose dependent effect reaching 37.4% for the basal inner hair cells. Interpretation of these results is limited because of the lack of data concerning the presence of specific membrane receptors. One possibility is that insulin stimulates hair cell differentiation from existing undifferentiated cells. Another hypothesis may be related to the EGF and transforming growth factor-beta, where these molecules might induce transdifferentiation of cells by acting on the transmembrane molecules and the extracellular matrix.
Chardin
S
S
Laboratoire de Neurobiologie, Université Blaise Pascal-Clermont II, 63177 Aubicre, France.
Romand
R
R
D000818:Animals; D000831:Animals, Newborn; D002452:Cell Count; D002478:Cells, Cultured; D003051:Cochlea / Q000166:cytology* / Q000502:physiology*; D003470:Culture Media; D004815:Epidermal Growth Factor / Q000494:pharmacology; D004847:Epithelial Cells; D004848:Epithelium / Q000502:physiology; D006199:Hair Cells, Auditory, Inner / Q000502:physiology*; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology; D009416:Nerve Regeneration / Q000502:physiology; D009924:Organ Culture Techniques; D051381:Rats; D017207:Rats, Sprague-Dawley; D016211:Transforming Growth Factor alpha / Q000494:pharmacology; D016212:Transforming Growth Factor beta / Q000494:pharmacology; D014212:Tretinoin / Q000494:pharmacology
D003470:Culture Media; D007004:Hypoglycemic Agents; D007328:Insulin; D016211:Transforming Growth Factor alpha; D016212:Transforming Growth Factor beta; D014212:Tretinoin; D004815:Epidermal Growth Factor